2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Ethylene Carbodiimide Fixed Donor Splenocytes Combined with α-1 Antitrypsin Induce Indefinite Donor Specific Protection to Mice Cardiac Allografts.

G. Chen, X. Lai, L. Qiu, Y. Zhao, S. Yu, J. Zhang, L. Chen.
Etiology and Timing of ESRD After Kidney Donation.

A. Matas, D. Berglund, B. Sengupta, H. Ibrahim.
Evaluating Online Information on Youtube for Kidney Transplant.

P. Sheiner, S. Silver.
Evaluating Patients' Experiences Towards Their Immunosuppressive Treatment: A Way to Improve Adherence.

C. Villeneuve,^1,2 M. Grau,¹ M. Essig,^2,3 S. Hegarat,³ J. Zoughbi,³ P. Marquet,^1,2 C. Monchaud.^1,2
Evaluating T Cell Repopulation Post Alemtuzumab Induction with a Belatacept-Based Regimen.

V. Bendersky, H. Xu, A. Kirk.
Evaluation of Cytomegalovirus Prophylaxis Regimens in Intestinal Transplant Recipients: A Single Center Experience.

M. Eley,¹ M. Keck,¹ D. Collier,² M. Vacha.¹
Evaluation of Function and TCR signaling Profile of CD57⁺ T Cells in Allo-Specific Immunity.

H. Xu,¹ T. Brennan,¹ Q. Li,² A. Kirk.¹
Evaluation of Graft Functional Recovery After Simultaneously Pancreas and Kidney Transplantation with Donation After Cardiac Death in China (16 Cases of Report).

A. Hu, W. Liao, C. Zhang, X. Zhu, X. He.
Evaluation of Immunological States of Patients with Cytomegalovirus Infection After Kidney Transplantation.

A. Tanaka, K. Ide, Y. Tanaka, K. Ishiyama, M. Ohira, H. Tahara, S. Shimizu, D. Kumar, H. Ohdan.
Evaluation of Low Dose Valganciclovir for the Prevention of Cytomegalovirus in Liver Transplant Recipients.

C. Payne,¹ J. Melaragno,¹ D. Hutchinson,¹ T. Babu,² P. Prasad,^2,3 T. Dick.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z